Why the study?
Bleeding is a key complication of bariatric surgery, and the effect of propranolol on reducing blood loss in bariatric surgery had not yet been investigated.
Does oral propranolol reduce intraoperative bleeding in patients with morbid obesity undergoing minimally invasive gastric bypass surgery?
Does oral propranolol reduce intraoperative bleeding in patients with morbid obesity undergoing minimally invasive gastric bypass surgery?
This trial investigates whether oral propranolol can reduce intraoperative bleeding during minimally invasive gastric bypass surgery in morbidly obese patients.
Answers are grounded in this paper and cite their sources.
Propranolol pretreatment may reduce bleeding sites and hemostasis time in gastric bypass; extends perioperative beta-blocker evidence to bariatric surgery.
Surgical treatment of patients with morbid obesity is now the most successful way to return to active life and overcome its effects. Complications during surgery, but still are varied and plentiful. One of the most important of these effects is increased bleeding during surgery and may require further surgery is surgery duration. The use of propranolol in other operations under the impact of which is helpful in reducing blood loss in surgery Bariatric still not been investigated. The purpose of this study is the use of propranolol in reducing gastric bypass surgery is bleeding.
No takes yet. Share an insight, caveat, or question.
Khalooeifard et al. (2021) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: